Very late bioresorbable vascular scaffold thrombosis at 25 months post implantation.
作者信息
Chan Koo Hui, Seow Swee-Chong, Tan Huay Cheem
机构信息
Cardiac Department, National University Heart Centre, Singapore.
出版信息
Singapore Med J. 2017 Sep;58(9):571-572. doi: 10.11622/smedj.2017089.
Abstract
摘要
相似文献
1
Very late bioresorbable vascular scaffold thrombosis at 25 months post implantation.
Singapore Med J. 2017 Sep;58(9):571-572. doi: 10.11622/smedj.2017089.
2
A golden tube following bioresorbable scaffold implantation.
Kardiol Pol. 2020 Aug 25;78(7-8):782-783. doi: 10.33963/KP.15355. Epub 2020 May 11.
3
Very Late Bioresorbable Scaffold Thrombosis Caused by Intraluminal Scaffold Dismantling.
JACC Cardiovasc Interv. 2016 Sep 12;9(17):1844-7. doi: 10.1016/j.jcin.2016.05.041. Epub 2016 Aug 17.
4
Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
JACC Cardiovasc Interv. 2013 Mar;6(3):211-21. doi: 10.1016/j.jcin.2013.01.132.
5
A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
JACC Cardiovasc Interv. 2014 Jan;7(1):89-99. doi: 10.1016/j.jcin.2013.07.007. Epub 2013 Oct 16.
6
Malabsorption of a Bioresorbable Vascular Scaffold System Leading to Very Late In-Scaffold Restenosis More Than 3.5 Years After Implantation: Assessment by Optical Coherence Tomography.
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2571-2572. doi: 10.1016/j.jcin.2016.09.037. Epub 2016 Nov 23.
7
Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
Int J Cardiol. 2015;189:132-3. doi: 10.1016/j.ijcard.2015.04.018. Epub 2015 Apr 3.
8
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Circ Cardiovasc Interv. 2012 Oct;5(5):620-32. doi: 10.1161/CIRCINTERVENTIONS.112.971549. Epub 2012 Oct 9.
9
Subacute thrombosis after primary percutaneous coronary intervention with bioresorbable vascular scaffold implantation.
Kardiol Pol. 2015;73(4):300. doi: 10.5603/KP.2015.0060.
10
Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1264-1265. doi: 10.1016/j.jcin.2015.03.031.
本文引用的文献
1
Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.
J Am Coll Cardiol. 2015 Oct 27;66(17):1901-14. doi: 10.1016/j.jacc.2015.08.853.
2
Late Structural Discontinuity as a Possible Cause of Very Late Everolimus-Eluting Bioresorbable Scaffold Thrombosis.
JACC Cardiovasc Interv. 2015 Aug 24;8(10):e171-e172. doi: 10.1016/j.jcin.2015.03.035.
3
Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
EuroIntervention. 2015 May 19;11(1):e1-2. doi: 10.4244/EIJV11I1A14.
4
Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.
Circ Cardiovasc Interv. 2015 May;8(5). doi: 10.1161/CIRCINTERVENTIONS.114.002369.
5
Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
Int J Cardiol. 2015;189:132-3. doi: 10.1016/j.ijcard.2015.04.018. Epub 2015 Apr 3.
6
Very late thrombosis observed on optical coherence tomography 22 months after the implantation of a polymer-based bioresorbable vascular scaffold.
Eur Heart J. 2015 May 21;36(20):1273. doi: 10.1093/eurheartj/ehv046. Epub 2015 Mar 2.
7
OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.
J Am Coll Cardiol. 2014 Dec 9;64(22):2343-56. doi: 10.1016/j.jacc.2014.09.029. Epub 2014 Dec 1.
8
Very late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy.
Eur Heart J. 2015 Feb 7;36(6):393. doi: 10.1093/eurheartj/ehu419. Epub 2014 Oct 21.
9
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.
EuroIntervention. 2015 Feb;10(10):1144-53. doi: 10.4244/EIJY14M07_11.
10
Bioresorbable scaffolds: rationale, current status, challenges, and future.
Eur Heart J. 2014 Mar;35(12):765-76. doi: 10.1093/eurheartj/eht542. Epub 2013 Dec 23.
Zotero 插件